Resources search

Pharmacological treatment of mental disorders in primary health care

WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This manual provides "evidence-based information to health care professionals in primary health care, especially in low- and middle-income countries, to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence"

South African national HIV prevalence, incidence, behavior and communication survey 2008 : turning a tide among teenagers ?

SHISANA, O
et al
2009

Expand view

"South Africa has the largest burden of HIV/AIDS and is currently implementing the largest antiretroviral treatment (ART) programme in the world. It is therefore fitting that South Africa is the first in the world to conduct three repeated national HIV population-based surveys to help monitor our response as a nation to the HIV/AIDS epidemic. This report is the third in a time series of population-based HIV seroprevalence surveys which started in 2002 and were repeated in 2005 and again in 2008"

The Lancet : essential medicines out of reach of most people

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
December 2008

Expand view

The lead article of this edition of the WHO and HAI medicines pricing survey quarterly bulletin picks up on an article published in the Lancet which highlights the financial burden faced by many people living in low and middle income countries when having to pay for essential medicines

UN MDG gap task force report

HEALTH ACTION INTERNATIONAL (HAI)
WORLD HEALTH ORGANIZATION (WHO)
September 2008

Expand view

Making essential medicines more affordable and more widely available are essential in helping to meet the millennium development goals. The lead article of this edition of HAI and WHO's medicines pricing survey bulletin, looks at UN Secretary General Ban Ki Moon's response to a mid-term progress report from the MDG Gap Task Force

Seizing the opportunity on AIDS and health systems

OOMMAN, Nandini
BERNSTEIN, Michael
ROSENZWEIG, Steven
August 2008

Expand view

This is a comparison of donor interactions with national health systems in Mozambique, Uganda, and Zambia - specifically: the health information systems, the supply chain systems for essential medicines, and human resources for health. It focuses on the US President’s Emergency Plan for AIDS Relief, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank’s Africa Multi-Country AIDS Program

Mapping factors that drive drug resistance (with a focus on resource-limited settings) : a first step towards better informed policy

BEITH, Alexandra
July 2008

Expand view

This paper characterises the drug resistance problem in developing countries. It presents an overview of the magnitude of resistance to drugs among organisms responsible for high burden diseases and then analyses key drivers of drug resistance by classifying them into three major categories to draw out commonalities in drivers across diseases. The paper also highlights gaps in knowledge about resistance, and priority areas for further research and potential policy dialogue

Benchmarking antiretroviral prices in countries of the former Soviet Union

WANING, Brenda
et al
June 2008

Expand view

This study benchmarks ARV prices of former Soviet Union (FSU) countries against each other and against global and European region ARV prices. The study reveals that extreme price variation exists within and across FSU countries for identical ARVs, which suggests that some countries may be able to obtain ARVs at lower prices and therefore purchase additional ARVs to treat more people

Antimalarial drug quality in the most severely malarious parts of Africa - a six country study

BATE, Roger
COTICELLI, Philip
TREN, Richard
ATTARAN, Amir
May 2008

Expand view

This article describes research conducted on a range of antimalarial drugs, procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries which were subjected to semi-quantitative thin-layer chromatography (TLC) and dissolution testing to measure active pharmaceutical ingredient content against internationally acceptable standards

Counterfeit drugs kill

INTERNATIONAL MEDICAL PRODUCTS ANTI-COUNTERFEITING TASKFORCE (IMPACT)
May 2008

Expand view

This leaflet describes how counterfeit medicines may endanger people's health because their quality is unpredictable. It also considers the challenges faced in combating counterfeit medicines and the role of the IMPACT coalition

Public and private sector approaches to improving pharmaceutical quality in Bangladesh

KOSTERMANS, Kees
et al
March 2008

Expand view

"Low-cost high-quality drugs benefit society and helps provide pharmaceutical companies a competitive edge. This study presents the issues that must be considered to achieve these common objectives in Bangladesh and explores options that the Government and the local industry could pursue. "Previous efforts to improve the drug quality in Bangladesh focused, without much success, on stricter regulation of the public market. This paper addresses this issue from a more private sector approach. The existing quality and price of pharmaceuticals are analysed and alternative mechanisms are explored to improve the quality and cost competitiveness of Bangladesh’s pharmaceuticals domestically and internationally"

Rickets : an overview and future directions, with special reference to Bangladesh

CRAVIARI, Thierry
March 2008

Expand view

"This article provides an overview of the history, epidemiology, clinical findings, treatment, and prevention of nu¬tritional rickets from both global and Bangladeshi perspectives. In so doing, an agendum for future research is proposed"
Rickets Convergence Group Meeting
Dhaka, Bangladesh
26-27 January 2006
Journal of Health, Population and Nutrition (JHPN), 26(1)

Measuring medicine prices, availability, affordability and price components

WORLD HEALTH ORGANIZATION (WHO)
HEALTH ACTION INTERNATIONAL (HAI)
2008

Expand view

This manual is to help governments, civil society groups and others concerned about the prices of medicines to collect and analyse: medicine prices (patient prices and government procurement prices) across sectors and regions in a country; medicine availability; treatment affordability; and all price components in the supply chain from manufacturer to patient (taxes, mark-ups etc.). It is accompanied by a CD-ROM which contains a more extensive collection resources and tools, such as sample training materials, frequently asked questions, and a report template for use in developing national survey reports

Towards universal access : scaling up priority HIV/AIDS interventions in the health sector : progress report 2008

WORLD HEALTH ORGNAIZATION (WHO)
JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS)
UNITED NATIONS CHILDREN'S FUND (UNICEF)
2008

Expand view

This report provides in-depth information on: treatment and care for people living with HIV; HIV testing and counselling; health sector interventions for HIV prevention; scaling up HIV services for women and children; strengthening health systems and health information; and towards universal access as the way forward

Knowledge for action on equity in health in Uganda

MAKERERE UNIVERSITY, SCHOOL OF PUBLIC HEALTH
HEPS UGANAD - COALITION FOR HEALTH PROMOTION AND SOCIAL DEVELOPMENT
2008

Expand view

This is the report of a national meeting to promote policies for equity in health. It brought together government, academic and civil society institutions to explore, understand and propose options for reducing inequalities in health in Uganda

Pages

E-bulletin